• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人血浆和血小板因子 XIII 在有机汞琼脂糖上的亲和层析。

Affinity chromatography of human plasma and platelet factor XIII on organomercurial agarose.

作者信息

Mcdonagh J, Waggoner W G, Hamilton E G, Hindenbach B, Mcdonagh R P

出版信息

Biochim Biophys Acta. 1976 Oct 28;446(2):345-57. doi: 10.1016/0005-2795(76)90002-7.

DOI:10.1016/0005-2795(76)90002-7
PMID:990283
Abstract

A method for affinity chromatography of plasma and platelet factor XIII has been developed, based on known structural characteristics of these molecules. Plasma factor XIII is composed of a and b subunits which are held together by noncovalent interactions; platelet factor XIII has only a subunits. a subunit contains free sulfhydryl groups, while in b subunit all the cystines form disulfide bonds. The affinity gel is an organomercurial agarose with p-chloromercuribenzoate as the reactive group. Both the zymogen and activated forms of a subunit reversibly bind to the ligand by forming covalent mercaptide bonds and are eluted by reducing agents. b subunit does not bind to the affinity gel and is held to it only through interaction with a subunit. Affinity chromatography can be used to purify plasma and platelet factor XIII and to study interactions of the subunits. Experiments on the affinity chromatography of purified plasma factor XIII in several stages of activation agree with earlier observations that activation is a two-step procedure in which b subunit is not quantitatively released from the complex until the final stage of activation by Ca2+.

摘要

基于血浆和血小板因子 XIII 的已知结构特征,已开发出一种用于它们亲和层析的方法。血浆因子 XIII 由通过非共价相互作用结合在一起的 a 亚基和 b 亚基组成;血小板因子 XIII 仅含有 a 亚基。a 亚基含有游离巯基,而 b 亚基中的所有胱氨酸均形成二硫键。亲和凝胶是一种以对氯汞苯甲酸为反应基团的有机汞琼脂糖。a 亚基的酶原形式和活化形式均通过形成共价硫醇盐键与配体可逆结合,并被还原剂洗脱。b 亚基不与亲和凝胶结合,仅通过与 a 亚基的相互作用而与之结合。亲和层析可用于纯化血浆和血小板因子 XIII 并研究亚基间的相互作用。对纯化的血浆因子 XIII 在几个活化阶段进行亲和层析的实验与早期观察结果一致,即活化是一个两步过程,其中直到被 Ca2+ 激活的最后阶段,b 亚基才从复合物中定量释放。

相似文献

1
Affinity chromatography of human plasma and platelet factor XIII on organomercurial agarose.人血浆和血小板因子 XIII 在有机汞琼脂糖上的亲和层析。
Biochim Biophys Acta. 1976 Oct 28;446(2):345-57. doi: 10.1016/0005-2795(76)90002-7.
2
Single step purification of platelet factor XIII using an immobilized factor XIII a-subunit monoclonal antibody.
Thromb Haemost. 1993 Apr 1;69(4):397-400.
3
Noncatalytic subunits of human blood plasma coagulation factor XIII. Preparation and partial characterization of modified forms.
J Biol Chem. 1980 Sep 25;255(18):8881-6.
4
Platelet factor XIII. The collagen receptor?血小板因子 XIII。胶原蛋白受体?
J Biol Chem. 1986 Jan 25;261(3):1355-8.
5
On the activation of bovine plasma factor XIII. Amino acid sequence of the peptide released by thrombin and the terminal residues of the subunit polypeptides.关于牛血浆因子XIII的激活。凝血酶释放的肽的氨基酸序列以及亚基多肽的末端残基。
J Biochem. 1975 Dec;78(6):1247-66. doi: 10.1093/oxfordjournals.jbchem.a131023.
6
The subunit structures of human plasma and platelet factor XIII (fibrin-stabilizing factor).人血浆和血小板因子 XIII(纤维蛋白稳定因子)的亚基结构。
J Biol Chem. 1971 Sep 25;246(18):5851-4.
7
Plasma factor XIII binds specifically to fibrinogen molecules containing gamma chains.血浆因子 XIII 特异性结合含有γ链的纤维蛋白原分子。
Biochemistry. 1996 Aug 13;35(32):10448-53. doi: 10.1021/bi9606206.
8
[Rat thrombocyte factor XIII and its role in platelet aggregation].[大鼠血小板因子 XIII 及其在血小板聚集中的作用]
Biull Eksp Biol Med. 1979 Feb;87(2):99-101.
9
Electron microscopy and hydrodynamic properties of factor XIII subunits.凝血因子 XIII 亚基的电子显微镜观察及流体动力学特性
J Biol Chem. 1989 Jan 5;264(1):551-6.
10
High-performance liquid chromatographic assay of transglutaminase and its application to the purification of human erythrocyte transglutaminase and platelet factor XIII.转谷氨酰胺酶的高效液相色谱分析及其在人红细胞转谷氨酰胺酶和血小板因子XIII纯化中的应用。
J Biochem. 1987 Jun;101(6):1331-7. doi: 10.1093/oxfordjournals.jbchem.a122000.

引用本文的文献

1
Site specific identification of endogenous S-nitrosocysteine proteomes.内源性 S-亚硝基半胱氨酸蛋白质组的位点特异性鉴定。
J Proteomics. 2013 Oct 30;92:195-203. doi: 10.1016/j.jprot.2013.05.033. Epub 2013 Jun 5.
2
A factor X-activating cysteine protease from malignant tissue.一种来自恶性组织的X因子激活半胱氨酸蛋白酶。
J Clin Invest. 1981 Jun;67(6):1665-71. doi: 10.1172/jci110203.
3
A compilation of amino acid analyses of proteins. XVIII. Residues per thousand residues--5.蛋白质氨基酸分析汇编。第十八部分。每千个残基中的残基数——5
Appl Biochem Biotechnol. 1983 Aug;8(4):315-68. doi: 10.1007/BF02779498.
4
Secondary-site binding of Glu-plasmin, Lys-plasmin and miniplasmin to fibrin.谷氨酸纤溶酶、赖氨酸纤溶酶和微型纤溶酶与纤维蛋白的次要位点结合。
Biochem J. 1981 Sep 1;197(3):619-28. doi: 10.1042/bj1970619.
5
Identification of intracellular factor XIII in human monocytes and macrophages.人单核细胞和巨噬细胞中细胞内凝血因子 XIII 的鉴定。
J Clin Invest. 1985 Aug;76(2):528-34. doi: 10.1172/JCI112002.
6
Non-proteolytic activation of cellular protransglutaminase (placenta macrophage factor XIII).细胞型谷氨酰胺转移酶(胎盘巨噬细胞因子 XIII)的非蛋白水解激活
Biochem J. 1990 Apr 15;267(2):557-60. doi: 10.1042/bj2670557.
7
Difference between type I autoimmune inhibitors of fibrin stabilization in two patients with severe hemorrhagic disorder.两名严重出血性疾病患者中I型纤维蛋白稳定自身免疫抑制剂的差异。
J Clin Invest. 1978 May;61(5):1196-203. doi: 10.1172/JCI109035.